Improving use of proton pump inhibitors with dual antiplatelet therapy in patients admitted with acute coronary syndrome

Acute coronary syndrome (ACS) is one of the leading causes of morbidity and mortality with a major impact on healthcare resources and expenditure. Dual antiplatelet therapy (DAPT) is recommended for the treatment of ACS. DAPT is associated with an increased risk of gastrointestinal (GI) bleeding, wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Jinadu, Tomilola, Radhakrishnan, Ashwin, Fan, Lampson
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Quality Improvement Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791429/
https://www.ncbi.nlm.nih.gov/pubmed/36564103
http://dx.doi.org/10.1136/bmjoq-2022-001956

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791429/
https://www.ncbi.nlm.nih.gov/pubmed/36564103
http://dx.doi.org/10.1136/bmjoq-2022-001956

Ejemplares similares